BNIP3-Dependent Mitophagy Via PGC1α Promotes Cartilage Degradation
Overview
Biophysics
Cell Biology
Molecular Biology
Authors
Affiliations
Since mitochondria are suggested to be important regulators in maintaining cartilage homeostasis, turnover of mitochondria through mitochondrial biogenesis and mitochondrial degradation may play an important role in the pathogenesis of osteoarthritis (OA). Here, we found that mitochondrial dysfunction is closely associated with OA pathogenesis and identified the peroxisome proliferator-activated receptor-gamma co-activator 1-alpha (PGC1α) as a potent regulator. The expression level of PGC1α was significantly decreased under OA conditions, and knockdown of PGC1α dramatically elevated the cartilage degradation by upregulating cartilage degrading enzymes and apoptotic cell death. Interestingly, the knockdown of PGC1α activated the parkin RBR E3 ubiquitin protein ligase (PRKN)-independent selective mitochondria autophagy (mitophagy) pathway through the upregulation of BCL2 and adenovirus E1B 19-kDa-interacting protein 3 (BNIP3). The overexpression of BNIP3 stimulated mitophagy and cartilage degradation by upregulating cartilage-degrading enzymes and chondrocyte death. We identified microRNA (miR)-126-5p as an upstream regulator for PGC1α and confirmed the direct binding between miR-126-5p and 3' untranslated region (UTR) of PGC1α. An in vivo OA mouse model induced by the destabilization of medial meniscus (DMM) surgery, and the delivery of antago-miR-126 via intra-articular injection significantly decreased cartilage degradation. In sum, the loss of PGC1α in chondrocytes due to upregulation of miR-126-5p during OA pathogenesis resulted in the activation of PRKN-independent mitophagy through the upregulation of BNIP3 and stimulated cartilage degradation and apoptotic death of chondrocytes. Therefore, the regulation of PGC1α:BNIP3 mitophagy axis could be of therapeutic benefit to cartilage-degrading diseases.
Recent development of mitochondrial metabolism and dysfunction in osteoarthritis.
Guo P, Alhaskawi A, Adel Abdo Moqbel S, Pan Z Front Pharmacol. 2025; 16:1538662.
PMID: 40017603 PMC: 11865096. DOI: 10.3389/fphar.2025.1538662.
Fasting activates optineurin-mediated mitophagy in chondrocytes to protect against osteoarthritis.
Zhang M, Duan R, Chen G, Chen M, Hong C, Wang X Commun Biol. 2025; 8(1):68.
PMID: 39820028 PMC: 11739490. DOI: 10.1038/s42003-025-07541-x.
Liu B, Liu T, Li Y, Tan C Int J Mol Sci. 2025; 25(24.
PMID: 39769149 PMC: 11677281. DOI: 10.3390/ijms252413384.
From dysfunction to healing: advances in mitochondrial therapy for Osteoarthritis.
Zhang M, Wu J, Cai K, Liu Y, Lu B, Zhang J J Transl Med. 2024; 22(1):1013.
PMID: 39529128 PMC: 11552139. DOI: 10.1186/s12967-024-05799-z.
Li K, Xia X, Tong Y Front Cell Dev Biol. 2024; 12:1453365.
PMID: 39445333 PMC: 11496291. DOI: 10.3389/fcell.2024.1453365.